Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

DETROIT – A Canadian man on Homeland Security’s Most Wanted list has been sentenced in a Detroit courtroom for nearly a decade of drug trafficking. According to authorities, 43-year-old ...

Accurate medication reconciliation is essential in early-phase oncology clinical trials, where drug-drug interactions (DDIs), eligibility criteria, and patient safety are closely scrutinized. 1 ...

Immunic will continue developing its multiple sclerosis (MS) drug, vidofludimus calcium (IMU-838), despite a Phase II trial missing its primary endpoint. Topline data from the ongoing CALLIPER ...

Key Takeaways Implementing the Medicare $2 drug list model would have reduced out-of-pocket spending by 63% for Part D beneficiaries in 2021. The model caps cost-sharing at $2 for a 30-day supply ...

Health Care Drug compounders sue over weight loss drugs’ removal from FDA shortage list by Joseph Choi - 02/25/25 4:46 PM ET Andrew Harnik, Associated Press file ...

GLP-1 Drugs: FDA Removes Semaglutide from the Drug Shortage List by: Nathan A. Beaver, David L. Rosen, Kyle Y. Faget of Foley & Lardner LLP - Insights/Publications Tuesday, February 25, 2025 ...

The FDA’s drug shortage list now states that as of Feb. 21, 2025, the shortages of Ozempic and Wegovy injections are over. The shortages were first declared in August 2022.

The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can meet present and future demand, Novo Nordisk and the FDA announced. On ...

Weight loss drug on list of 15 whose prices will be negotiated under President Biden’s Inflation Reduction Act. Also on the list: Trelegy Ellipta, Xtandi.

The National Institute for Occupational Safety and Health (NIOSH) has published the 2024 update to its List of Hazardous Drugs in Healthcare Settings, marking the first revision since 2016.